Immunogenicity of inactivated Escherichia coli O157:H7 with Stx2B microparticle in mice

Objective(s): Vaccination using inactivated bacteria is one of the most effective ways to protect against EHEC infection. Escherichia coli O157:H7 infections are mainly influenced by Shiga toxins (Stx) and attaching/effacing factors. Among various factors, Stx2B is gaining much attention as a vaccin...

Full description

Bibliographic Details
Main Authors: Nasim Arshadi, Seyed Latif Mousavi Gargari, Jafar Amani, Shahram Nazarian
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2022-09-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
Online Access:https://ijbms.mums.ac.ir/article_20903_3174b4ac2590278fac5695a59e94b9b6.pdf
_version_ 1811192529666703360
author Nasim Arshadi
Seyed Latif Mousavi Gargari
Jafar Amani
Shahram Nazarian
author_facet Nasim Arshadi
Seyed Latif Mousavi Gargari
Jafar Amani
Shahram Nazarian
author_sort Nasim Arshadi
collection DOAJ
description Objective(s): Vaccination using inactivated bacteria is one of the most effective ways to protect against EHEC infection. Escherichia coli O157:H7 infections are mainly influenced by Shiga toxins (Stx) and attaching/effacing factors. Among various factors, Stx2B is gaining much attention as a vaccine candidate. Formulating an inactivated bacteria with a suitable adjuvant increases vaccine efficacy and antibody production and can lead to a lasting immune response and protection against O157:H7. Materials and Methods: To assess vaccine efficacy, in this study, we have considered heat and formalin-inactivated bacteria along with chitosan-coated Stx2B/ Stx2B in a mouse model. Ionotropic gelation via tripolyphosphate anions was used to coat Stx2B on chitosan. Subcutaneous injection or oral gavage was used to immunize mice, which were then challenged with E. coli O157:H7. Results: Immunity and protection against E. coli  O157:H7 were achieved by all forms of the vaccine. Inactivated E. coli  O157:H7 formulated with chitosan-coated Stx2B effectively evoked humoral and mucosal immune responses. However, minimum shedding appeared with the mice groups orally immunized with formalin-inactivated bacteria sublimated with chitosan-coated Stx2B and heat-inactivated bacteria plus Stx2B in subcutaneous immunization.Conclusion: Administration of inactivated whole-cell and toxin was synergistic and increased the protection capacity with both parenteral and oral immunization routes.
first_indexed 2024-04-11T23:54:07Z
format Article
id doaj.art-6bf4f3e489a641be8f28ed2e82f96791
institution Directory Open Access Journal
issn 2008-3866
2008-3874
language English
last_indexed 2024-04-11T23:54:07Z
publishDate 2022-09-01
publisher Mashhad University of Medical Sciences
record_format Article
series Iranian Journal of Basic Medical Sciences
spelling doaj.art-6bf4f3e489a641be8f28ed2e82f967912022-12-22T03:56:24ZengMashhad University of Medical SciencesIranian Journal of Basic Medical Sciences2008-38662008-38742022-09-012591069107610.22038/ijbms.2022.63775.1405320903Immunogenicity of inactivated Escherichia coli O157:H7 with Stx2B microparticle in miceNasim Arshadi0Seyed Latif Mousavi Gargari1Jafar Amani2Shahram Nazarian3Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, IranDepartment of Biology, Faculty of Basic Sciences, Shahed University, Tehran, IranApplied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, IranDepartment of Biology, Imam Hussein University, Tehran, IranObjective(s): Vaccination using inactivated bacteria is one of the most effective ways to protect against EHEC infection. Escherichia coli O157:H7 infections are mainly influenced by Shiga toxins (Stx) and attaching/effacing factors. Among various factors, Stx2B is gaining much attention as a vaccine candidate. Formulating an inactivated bacteria with a suitable adjuvant increases vaccine efficacy and antibody production and can lead to a lasting immune response and protection against O157:H7. Materials and Methods: To assess vaccine efficacy, in this study, we have considered heat and formalin-inactivated bacteria along with chitosan-coated Stx2B/ Stx2B in a mouse model. Ionotropic gelation via tripolyphosphate anions was used to coat Stx2B on chitosan. Subcutaneous injection or oral gavage was used to immunize mice, which were then challenged with E. coli O157:H7. Results: Immunity and protection against E. coli  O157:H7 were achieved by all forms of the vaccine. Inactivated E. coli  O157:H7 formulated with chitosan-coated Stx2B effectively evoked humoral and mucosal immune responses. However, minimum shedding appeared with the mice groups orally immunized with formalin-inactivated bacteria sublimated with chitosan-coated Stx2B and heat-inactivated bacteria plus Stx2B in subcutaneous immunization.Conclusion: Administration of inactivated whole-cell and toxin was synergistic and increased the protection capacity with both parenteral and oral immunization routes.https://ijbms.mums.ac.ir/article_20903_3174b4ac2590278fac5695a59e94b9b6.pdfchitosanescherichia coli o157:h7inactivated vaccineoral vaccineshiga toxin
spellingShingle Nasim Arshadi
Seyed Latif Mousavi Gargari
Jafar Amani
Shahram Nazarian
Immunogenicity of inactivated Escherichia coli O157:H7 with Stx2B microparticle in mice
Iranian Journal of Basic Medical Sciences
chitosan
escherichia coli o157:h7
inactivated vaccine
oral vaccine
shiga toxin
title Immunogenicity of inactivated Escherichia coli O157:H7 with Stx2B microparticle in mice
title_full Immunogenicity of inactivated Escherichia coli O157:H7 with Stx2B microparticle in mice
title_fullStr Immunogenicity of inactivated Escherichia coli O157:H7 with Stx2B microparticle in mice
title_full_unstemmed Immunogenicity of inactivated Escherichia coli O157:H7 with Stx2B microparticle in mice
title_short Immunogenicity of inactivated Escherichia coli O157:H7 with Stx2B microparticle in mice
title_sort immunogenicity of inactivated escherichia coli o157 h7 with stx2b microparticle in mice
topic chitosan
escherichia coli o157:h7
inactivated vaccine
oral vaccine
shiga toxin
url https://ijbms.mums.ac.ir/article_20903_3174b4ac2590278fac5695a59e94b9b6.pdf
work_keys_str_mv AT nasimarshadi immunogenicityofinactivatedescherichiacolio157h7withstx2bmicroparticleinmice
AT seyedlatifmousavigargari immunogenicityofinactivatedescherichiacolio157h7withstx2bmicroparticleinmice
AT jafaramani immunogenicityofinactivatedescherichiacolio157h7withstx2bmicroparticleinmice
AT shahramnazarian immunogenicityofinactivatedescherichiacolio157h7withstx2bmicroparticleinmice